The increasing market complexity for the pharmaceutical industry is pushing them to focus on many other aspects of business apart from innovation. More and more every day small but highly flexible, fast and academic-
As a representative of the company founders who mainly come from the scientific and clinical arena, please allow me to share with you that Allinky has a personal commitment -
To render cell missignalling in all these diseases we have embarked in a intensive journey to discover novel therapeutics that change the shape of protein targets and thus modulating their activation status. If we hopefully touch ground at the end of the journey, these novel therapeutics will represent a step forward in the treatment of cancer, inflammation and chronic inflammatory conditions. We are working hard every day to fulfill the expectations we raised on our pharmaceutical partners and moreover on those suffering life-
Thank you for visiting our website!